The Evaluation of Cases with Ocular Complications due to Bacillus Calmette-Guerin (BCG) Treatment using the Pool Analysis Method

dc.authorid0000-0003-1944-2477en_US
dc.authorscopusid57526218800en_US
dc.authorwosidABH-8663-2020en_US
dc.contributor.authorAlkan, Sevil
dc.contributor.authorEvlice, Oğuz
dc.contributor.authorAğın, Abdullah
dc.date.accessioned2023-06-09T07:19:08Z
dc.date.available2023-06-09T07:19:08Z
dc.date.issued2021en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractObjective The aim of this study was to investigate cases with ocular complications associated with intravesical BCG therapy in terms of clinical features, demographic features and type of ocular involvement. Methods PubMed database was scanned for relevant publications using the keywords. Thirty-seven publications and 147 reported cases were identified related to the development of ocular complications due to intravesical BCG treatment. Results As a result of the analysis performed according to eye involvement, there were 17 cases of conjunctivitis, 7 uveitis, and 5 endophthalmitis. Only 27 (18.3%) cases were of primary ocular involvement and Reiter's syndrome was present in 120 (81.6%) of all cases. Conclusions Most of the side-effects of BCG therapy are minor and of short duration. Although rare, it has been reported that potentially serious ocular complications can develop after treatment. Physicians must keep these facts in mind and be alert to the development of ocular symptoms following BCG therapy.en_US
dc.identifier.citationAlkan, S., Evlice, O., & Ağın, A. (2022). The evaluation of cases with ocular complications due to bacillus calmette-guerin (BCG) treatment using the pool analysis method. Seminars in Ophthalmology, 37(3), 373-378. doi:10.1080/08820538.2021.1974060en_US
dc.identifier.doi10.1080/08820538.2021.1974060
dc.identifier.endpage378en_US
dc.identifier.issn0882-0538
dc.identifier.issn1744-5205
dc.identifier.issue3en_US
dc.identifier.pmid34543151
dc.identifier.scopus2-s2.0-85115260450
dc.identifier.startpage373en_US
dc.identifier.urihttps://www.doi.org/10.1080/08820538.2021.1974060
dc.identifier.urihttps://hdl.handle.net/20.500.12428/4266
dc.identifier.volume37en_US
dc.identifier.wosWOS:000697432600001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorAlkan, Sevil
dc.language.isoen
dc.publisherTaylor and Francis Ltd.en_US
dc.relation.ispartofSeminars in Ophthalmologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBacillus Calmette–Guérinen_US
dc.subjectBCGen_US
dc.subjectbladder canceren_US
dc.subjectintravesical BCGen_US
dc.subjectOcular tuberculosisen_US
dc.titleThe Evaluation of Cases with Ocular Complications due to Bacillus Calmette-Guerin (BCG) Treatment using the Pool Analysis Method
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
sevil_alkan_makale.pdf
Boyut:
586.65 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Araştırma Makalesi
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: